Goldman Sachs Group Inc Aspira Women'S Health Inc. Transaction History

Goldman Sachs Group Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 May 14, 2024	SELL	$0.38 - $1.07 $2,136 - $6,016	-5,623 Reduced 6.37%	82,610 $31,000
Q3 2022 Nov 10, 2022	SELL	$0.38 - $1.07 $2,136 - $6,016	-5,623 Reduced 6.37%	82,610 $0
Q2 2022 May 14, 2024	BUY	$0.4 - $1.09 $35,293 - $96,173	88,233 New	88,233 $52,000
Q2 2022 Aug 15, 2022	SELL	$0.4 - $1.09 $11,199 - $30,517	-27,998 Reduced 24.09%	88,233 $52,000
Q1 2022 May 16, 2022	SELL	$0.88 - $1.81 $234,322 - $481,959	-266,276 Reduced 69.61%	116,231 $121,000
Q4 2021 Feb 14, 2022	BUY	$1.63 - $3.43 $526,992 - $1.11 Million	323,308 Added 546.14%	382,507 $677,000
Q3 2021 Nov 10, 2021	BUY	$3.19 - $5.48 $188,844 - $324,410	59,199 New	59,199 $192,000

431K

Ticker AWH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 124,296,000
Market Cap $123M
Description
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gyneco...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.